"10.1371_journal.pone.0116202","plos one","2015-02-06T00:00:00Z","Yinghong An; Wanjun Guo; Linna Li; Chengwang Xu; Dexuan Yang; Shanshan Wang; Yaxin Lu; Quan Zhang; Jiadai Zhai; Hongxia Fan; Chuanjiang Qiu; Jie Qi; Yue Chen; Shoujun Yuan","Clinical Laboratory Center, Chinese PLA Air Force General Hospital, Haidian, Beijing 100142, PR China; Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China; College of Pharmacy, The State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, PR China; Accendatech Co., Ltd., Tianjin 300384, PR China","Conceived and designed the experiments: YA WG SY YC. Performed the experiments: YA WG LL YL QZ JZ. Analyzed the data: YA WG CX YL. Contributed reagents/materials/analysis tools: DY SW HF CQ JQ. Wrote the paper: YA.","Yue Chen is one of the founders of Accendatech Co., Ltd., which has a financial interest in DMAMCL. All other authors declare no competing financial interests. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials.","2015","02","Yinghong An","YA",14,TRUE,4,6,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
